455330-42-4Relevant articles and documents
Scalable Asymmetric Synthesis of the All Cis Triamino Cyclohexane Core of BMS-813160
La Cruz, Thomas E.,González-Bobes, Francisco,Eastgate, Martin D.,Sfouggatakis, Chris,Zheng, Bin,Kopp, Nathaniel,Xiao, Yi,Fan, Yu,Galindo, Kay A.,Pathirana, Charles,Galella, Michael A.
, p. 1996 - 2011 (2021/09/02)
BMS-813160 is a pharmaceutical entity currently in development at Bristol Myers Squibb. Its defining structural feature is a unique chiral all cis triamino cyclohexane core. Medicinal and process chemistry groups at BMS have previously published synthesis
Chemoenzymatic formal synthesis of (-)- and (+)-epibatidine
Boyd, Derek R.,Sharma, Narain D.,Kaik, Magdalena,McIntyre, Peter B. A.,Stevenson, Paul J.,Allen, Christopher C. R.
, p. 2774 - 2779,6 (2020/08/31)
The cis-dihydrocatechol, derived from enzymatic cis-dihydroxylation of bromobenzene using the microorganism Pseudomonas putida UV4, was converted into (-)-epibatidine in eleven steps with complete stereocontrol. In addition, an unprecedented palladium-catalysed disproportionation reaction gave the (+)-enantiomer of an advanced key intermediate employed in a previous synthesis of epibatidine.
α-iodocycloalkenones: Synthesis of (±)-epibatidine
Sirisoma, Nilantha S.,Johnson, Carl R.
, p. 2059 - 2062 (2007/10/03)
A synthesis of the non-opiate analgesic alkaloid epibatidine was achieved in 13 steps and 13% Overall yield starting from 1,3-cyclohexadiene using in a key step a modified Stille coupling reaction on an α- iodocyclohexenone.